Coenzyme Q10 concentration in the plasma of children suffering from acute lymphoblastic leukaemia before and during induction treatment

BioFactors

Volumn 29, Issue 2-3, 2007, Pages 83-89

  Niklowitz, Petra ^a   Wiesel, Thomas ^a   Andler, Werner ^a   Menke, Thomas ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Acute lymphoblastic leukaemia; Childhood; Coenzyme Q10; Plasma

Indexed keywords

ASPARAGINASE; DAUNORUBICIN; PREDNISONE; UBIDECARENONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DAMAGE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOLYSIS; ELECTROCHEMICAL DETECTION; ENDOCRINE SYSTEM; ENZYME BLOOD LEVEL; ENZYME SYNTHESIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; STANDARDIZATION; STEROID THERAPY;

EID: 34547764355     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.552029208     Document Type: Article

References (39)

1. A. Attarbaschi, G. Mann, M. Kronberger, V. Witt, H. Gadner and M. Dworzak, Effects of dose-reduced Medac L-asparaginase on coagulating in trial All-BFM 2000, Klin Padiatr 215 (6) (2003), 321-326.
2. E. Baggio, R. Gandini, A.C. Plancher, M. Passeri and G. Carmonsino, Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. CoQ10 Drug Surveillance Investigators, Mol Aspects Med 15 (1994), 287-294.
3. G. Brea-Calvo, A. Rodriguez-Hernandez, D.J.M. Fernandez-Ayala, P. Navas and J.A. Sanchez-Alcazar, Chemotherapy induces an increase in coenzyme Q10 levels in cancer cell lines, Free Rad Biol Med 40 (2006), 1293-1302.
4. P.A. Cerutti, Oxy radicals and cancer, Lancet 344 (1994), 862-863.
5. B. Chipperfield, Ubiquinone concentrations in tumours and some normal tissue in man, Nature 209 (1966), 1207-1209.
6. J.Y. Choe, A.B. Combs and K. Folkers, Prevention of coenzyme Q10 of the electrocardiographic changes induced by adriamycin in rats, Res Commun Chem Pathol Pharmacol 23(1) (1979), 199-202.
7. K.A. Conklin, Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutics effectiveness and development of side effects, Nutr Canc 37 (2000), 1-18.
8. F.L. Crane and E.E. Sum, The essential functions of Coenzyme Q, Clin Invest 71 (1993), 55-59.
9. D. Dreher and A.F. Junod AF, Role of oxygen free radicals in cancer development, Eur J Cancer 32A(1) (1996), 30-38.
10. S. Eaton, R. Skinner, J.P. Hale, M. Pourfarzam, A. Roberts, L. Price and K. Bartlett, Plasma coenzyme Q(10) in children and adolescents undergoing doxorubicin therapy, Clin Chim Acta 302 (2000), 1-9.
11. L. Ernster and G. Dallner, Biochemical, physiological and medical aspects of ubiquinone function, Biochim Biophys Acta 1271 (1995), 195-204.
12. K. Folkers, J.Y. Choe and A.B. Combs, Rescue by coenzyme Q10 from electrocardiographic abnormalities caused by the toxicity of adriamycin in the rat, Proc Natl Acad Sci USA 75(10) (1978), 5178-5180.
13. K. Folkers, S. Shizukuishi, K. Takemura, J. Drzewoski, P. Richardson, J. Ellis and W.C. Kuzell, Increase in levels of IgG in serum of patients treated with coenzyme Q10, Res Commun Chem Pathol Pharmacol 38(2) (1982), 335-338.
14. K. Folkers, Y. Ellis, O. Yang, H. Tamagawa, Y. Nara and K. Nara, Coenzyme Q10 deficiency in cancer patients: potential for immunotherapy with coenzym Q10, in: Vitamins and Cancer Prevention, Wiley-Liss, New York, 1991, 103-110.
15. K. Folkers, T. Hanioka, L.J. Xia, J.T. McRee Jr. and P. Langsjoen, Coenzyme Q10 increases T4/T8 ratios of lymphocytes in ordinary subjects and relevance to patients having the AIDS related complex, Biochem Biophys Res Commun 176(2) (1991), 786-791.
16. K. Folkers, A. Osterborg, M. Nylander, M. Morita and H. Mellstadt, Activities of vitamin Q(10) in animal models and a serious deficiency in patients with cancer, Biochem Biophys Res Commun 234 (1997), 296-299.
17. A.P. Forsmark and L. Ernster, Evidence for a protective effect of endogenous ubiquinol against oxidative damage to mitochondrial protein and DNA during lipid peroxidation, Mol Aspects Med 15 (1994), 73-81.
18. C. Hofman-Bang, N. Rehnquist, K. Swedberg, I. Wiklund and H. Astrom, Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 study group, J Card Fail 1 (1995), 101-107.
19. D. Iarussi, U. Auricchio, A. Agretto, A. Murano, M. Giuliano, F. Casale, P. Indolfi and A. Iacono, Protective effect of coenzyme Q10 on anthracyclines cardiotoxicity: control study in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma, Mol Aspects Med 15(Suppl) (1994), 207-212.
20. P. Jolliet, N. Simon, J. Barre, J.Y. Pons, M. Boukef, B.J. Paniel and J.P. Tillement, Plasma coenzyme Q10 concentrations in breast cancer: prognosis and therapeutic consequences, Int Clin Pharmacol Ther 36 (1998), 506-509.
21. K. Lockwood, S. Moesgaard and K. Folkers, Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10, Biochem Biophys Res Commun 199 (1994), 1504-1508.
22. K. Lockwood, S. Moesgaard, T. Hanioka and K. Folkers, Apparent partial remission of breast cancer in "high risk" patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10, Mol Aspects Med 15(Suppl) (1994), 231-240.
23. K. Lockwood, S. Moesgaard, T. Yamamoto and K. Folkers, Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases, Biochem Biophys Res Commun 212 (1995), 172-177.
24. T. Menke, P. Niklowitz, S. Adam, M. Weber, B. Schlüter and W. Andler, Simultaneous detection of ubiquinol-10, ubiquinone-10, and tocopherols in human plasma microsamples and macrosamples as a marker of oxidative damage in neonates and infants, Anal Biochem 282 (2000), 209-217.
25. C. Morisco, B. Trimarco and M. Condonelli, Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term, multicenter randomised study, Clin Investig 71 (1993), 134-136.
26. T. Mueller, T. Buettner, A.F. Gholipour and W. Kuhn, Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease, Neurosci Lett 341 (2003), 201-204.
27. P. Niklowitz, T. Menke, T. Wiesel, E. Mayatepek, J. Zschocke, J.G. Okun and W. Andler, Coenzyme Q10 in plasma and erythrocytes: comparison of antioxidant levels in healthy probands after oral supplementation and in patients suffering from sickle cell anemia, Clin Chim Acta 326 (2002), 155-161.
28. P. Niklowitz, T. Menke, W. Andler and J.G. Okun, Simultaneous analysis of coenzyme Q10 in plasma, erythrocytes and platelets: comparison of the antioxidant level in blood cells and their environment in healthy children and after oral supplementation in adults, Clin Chim Acta 342 (2004), 219-226.
29. O. Portakal, O. Ozkaya, M. Inal, B. Bozan, M. Kosan and I. Sayek, Coenzyme Q10 concentrations and antioxidant status in tissue of breast cancer patients, Clin Biochem 33 (2000), 279-284.
30. M. Schrappe, Therapiestudie ALL-BFM 2000, Multizentrische kooperative Therapiestudie zur Behandlung von Kindern und Jugendlichen mit akuter lymphoblastischer Leukämie, Medizinische Hochschule Hannover (2000).
31. M. Schrappe, A. Reiter, W.D. Ludwig, J. Harbott, M. Zimmermann, W. Hiddemann, C. Niemeyer, G. Henze, A. Feldges, F. Zintl, B. Kornhuber, J. Ritter, K. Welte, H. Gadner and H. Riehm, Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial All-BFM 90. german-Austrian-Swiss ALL-BFM Study Group, Blood 95(11) (2000), 3310-3322.
32. C.W. Shults, R.H. Haas and M.F. Beal, A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease, BioFactors 9 (1999), 267-272.
33. C.W. Shults, D. Oakes, K. Kieburts, M.F. Beal, R. Haas, S. Plumb, J.L. Juncos, J. Nutt, I. Shoulson, J. Carter, K. Kompoliti, J.S. Perlmutter, S. Reich, M. Stern, R.L. Watts, R. Kurlan, E. Molho, M. Harrison and M. Lew, Parkinson Study Group, Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing the functional decline, Arch Neurol 59 (2002), 1541-1550.
34. R. Stocker, Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does a-tocopherol, Proc Natl Acad Sci USA 88 (1991), 1646-1650.
35. D.A. Stoyanowski, A.N. Osipov, P.J. Quinn and V.E. Kagan, Ubiquinone-dependend recycling of vitamin E radicals by superoxide, Arch Biochem Biophys 323 (1995), 343-351.
36. M. Tomasetti, R. Alleva, M.D. Solinghi and G.P. Littarru, Distribution of antioxidants among blood components and lipoproteins: significance of lipids/CoQ10 ratio as a possibile marker of increased risk of atherosclerosis, BioFaktors 9 (1999), 231-240.
37. M. Turunen, E. Swiezewska, T. Chojnacki, P. Sindelar and G. Dallner, Regulatory aspects of Coenzyme Q10 metabolism, Free Rad Res 36 (2002), 437-443.
38. Y. Yamamoto and S. Yamashita, Plasma ratio of ubiquinol and ubiquinone as a marker of oxidative stress, Mol Aspects Med 18 (Suppl) (1997), S79-S84.
39. Y. Zang, F. Aberg, E.-L. Appelkvist, G. Dallner and L. Ernster, Uptake of dietary coenzyme Q supplement is limited in rats, J Nutr 154 (1995), 446-453.